- Home
- KYMR vs NNI Comparison
KYMR vs NNI Comparison
Compare KYMR & NNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- NNI
- Stock Information
- Founded
- KYMR 2015
- NNI 1978
- Country
- KYMR United States
- NNI United States
- Employees
- KYMR N/A
- NNI N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- NNI Finance: Consumer Services
- Sector
- KYMR Health Care
- NNI Finance
- Exchange
- KYMR Nasdaq
- NNI Nasdaq
- Market Cap
- KYMR 4.3B
- NNI 4.7B
- IPO Year
- KYMR 2020
- NNI 2003
- Fundamental
- Price
- KYMR $63.94
- NNI $130.46
- Analyst Decision
- KYMR Strong Buy
- NNI Hold
- Analyst Count
- KYMR 19
- NNI 1
- Target Price
- KYMR $68.95
- NNI $135.00
- AVG Volume (30 Days)
- KYMR 665.0K
- NNI 82.3K
- Earning Date
- KYMR 11-04-2025
- NNI 11-06-2025
- Dividend Yield
- KYMR N/A
- NNI 0.92%
- EPS Growth
- KYMR N/A
- NNI 288.59
- EPS
- KYMR N/A
- NNI 11.91
- Revenue
- KYMR $43,735,000.00
- NNI $1,698,851,000.00
- Revenue This Year
- KYMR $60.88
- NNI $12.03
- Revenue Next Year
- KYMR N/A
- NNI $5.34
- P/E Ratio
- KYMR N/A
- NNI $10.95
- Revenue Growth
- KYMR N/A
- NNI 35.52
- 52 Week Low
- KYMR $19.45
- NNI $98.15
- 52 Week High
- KYMR $65.69
- NNI $136.68
- Technical
- Relative Strength Index (RSI)
- KYMR 63.12
- NNI 51.53
- Support Level
- KYMR $56.75
- NNI $127.87
- Resistance Level
- KYMR $61.21
- NNI $136.68
- Average True Range (ATR)
- KYMR 3.12
- NNI 3.28
- MACD
- KYMR -0.01
- NNI -0.13
- Stochastic Oscillator
- KYMR 83.30
- NNI 30.43
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About NNI Nelnet Inc.
Nelnet Inc is a United States based company engaged in these four reportable segments; Loan Servicing and Systems focuses on student and consumer loan origination services and servicing, loan origination and servicing-related technology solutions, and outsourcing business services; Education Technology Services and Payments segment provides education services, payment technology, and community management solutions for K-12 schools, institutions, churches, and businesses; Asset Generation and Management segment includes the acquisition and management of student and other loan assets; and Nelnet Bank focuses on the private education and unsecured consumer loan markets. Maximum revenue for the company is generated from its Education Technology Services and Payments segment.